| 000 | 01871 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517104033.0 | ||
| 264 | 0 | _c20170711 | |
| 008 | 201707s 0 0 eng d | ||
| 022 | _a2326-5205 | ||
| 024 | 7 |
_a10.1002/art.39797 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCastelino, Flavia V | |
| 245 | 0 | 0 |
_aAn Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis. _h[electronic resource] |
| 260 |
_bArthritis & rheumatology (Hoboken, N.J.) _c12 2016 |
||
| 300 |
_a2964-2974 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBenzoates _xpharmacology |
| 650 | 0 | 4 |
_aBleomycin _xtoxicity |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibroblasts _xdrug effects |
| 650 | 0 | 4 | _aFibrosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aInterleukin-6 _xmetabolism |
| 650 | 0 | 4 |
_aLysophospholipids _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPhosphoric Diester Hydrolases _xdrug effects |
| 650 | 0 | 4 | _aRNA, Small Interfering |
| 650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aScleroderma, Systemic _xmetabolism |
| 650 | 0 | 4 |
_aSkin _xmetabolism |
| 700 | 1 | _aBain, Gretchen | |
| 700 | 1 | _aPace, Veronica A | |
| 700 | 1 | _aBlack, Katharine E | |
| 700 | 1 | _aGeorge, Leaya | |
| 700 | 1 | _aProbst, Clemens K | |
| 700 | 1 | _aGoulet, Lance | |
| 700 | 1 | _aLafyatis, Robert | |
| 700 | 1 | _aTager, Andrew M | |
| 773 | 0 |
_tArthritis & rheumatology (Hoboken, N.J.) _gvol. 68 _gno. 12 _gp. 2964-2974 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.39797 _zAvailable from publisher's website |
| 999 |
_c26202646 _d26202646 |
||